Eledon Reports Tegoprubart Data: 6 T1D Patients Insulin-Free
Eledon (NASDAQ: ELDN) reported preliminary results from the first six type 1 diabetes patients in an investigator-initiated islet transplant trial using tegoprubart…
Eledon (NASDAQ: ELDN) reported preliminary results from the first six type 1 diabetes patients in an investigator-initiated islet transplant trial using tegoprubart…
The number of New Yorkers at risk of developing Type 2 diabetes more than doubled between 2011 and 2023, according to recent data released by the state Department of Health.…
Data source The data used in this study are from the Danish national health registers. All health data is reported when a patient among others is hospitalized, visits a GP,…
In this week’s issue of The Savvy Diabetic: FDA Approves Kristy – Biosimilar to Novolog Dexcom Responds to Sensor Failures & More ‘Ozempic Teeth’ GLP-1 Side Effect Innovations in Preventing/Treating…
BORIS KOVATCHEV and PHD are the directors of the UVA Diabetes Technology Center. Virginia University Diabetes Researcher was discovered that data from continuous glucose monitors could predict nerves, eyes, and…
specialty please selectI'm not a medical professional.Allergy and immunologyanatomyanesthesiologybiostatisticsCardiac, thoracic, and vascular surgerycardiologycritical caredentaldermatologyDiabetes and endocrinologyemergency medical careepidemiology and public healthfamily medicineForensic medicineGastroenterologyGeneral medical treatmentgeneticsgeriatricsmedical policyhematologyHIV/AIDShospital-based medical careI'm not a…
Written by Francesco Guaracio and Phuong Nguyen HANOI – US technology companies have warned the Vietnamese government that a bill to tighten data protection rules and limit data transfers abroad…
NatureThe role of DNA damage in diabetic complications Mechanistic and clinical data suggest that DNA damage contributes to the development and progression of diabetic complications. 1 week ago
data All data utilized in this study were obtained from the UK Biobank, a comprehensive biomedical database containing extensive health information for 502,625 people living in the UK. Baseline assessments…
New data shows long-term use of an AID system powered by Dexcom CGM can safely maintain improvements in glycaemic outcomes for up to two years1. Real-world evidence demonstrates reduction in…